Anemia: latest news - GoINPHARMA
Sunday, 19 May 2019 - 13:44


Novartis acquires Selexys for $665m

Novartis acquired Selexys Pharmaceuticals for $665. The Swiss company exercised its right to acquire Selexys—which it had been retaining since 2012—following the clinical results of a phase II trial evaluating a product of the group. Selexys is a US-based company…